Global Bioelectric Medicine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Bioelectric Medicine Market to foresee a significant growth in the industry over the upcoming years. The global bioelectric medicine market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global bioelectric medicine market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this bioelectric medicine market.

The next sections of the bioelectric medicine market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Product

Cardiac Pacemakers

Implantable Cardioverter Defibrillators

Spinal Cord Stimulators

Cochlear Implants

Deep Brain Stimulators

Sacral Nerve Stimulators & Gastric Electrical Stimulators

Transcutaneous Electrical Nerve Stimulators

Vagus Nerve Stimulators

Other Electrical Stimulators

By Type

Implantable Electroceutical Devices

Noninvasive Electroceutical Devices

By Application

Chronic Pain

Arrhythmia

Failed Back Surgery Syndrome

Cerebral Ischemia

Urinary Incontinence

Fecal Incontinence

Gastroparesis

Parkinson's Disease

Tremors

Depression

Treatment-resistant Depression

Epilepsy

Others

By End Use

Hospitals

Clinics

Ambulatory Surgery Centers

Others

Product Code: VMR11218485

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BIOELECTRIC MEDICINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End Use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL BIOELECTRIC MEDICINE MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Cardiac Pacemakers Historic and Forecast Sales by Regions
6.5 Implantable Cardioverter Defibrillators Historic and Forecast Sales by Regions
6.6 Spinal Cord Stimulators Historic and Forecast Sales by Regions
6.7 Cochlear Implants Historic and Forecast Sales by Regions
6.8 Deep Brain Stimulators Historic and Forecast Sales by Regions
6.9 Sacral Nerve Stimulators & Gastric Electrical Stimulators Historic and Forecast Sales by Regions
6.10. Transcutaneous Electrical Nerve Stimulators Historic and Forecast Sales by Regions
6.11 Vagus Nerve Stimulators Historic and Forecast Sales by Regions
6.12 Other Electrical Stimulators Historic and Forecast Sales by Regions

7 . GLOBAL BIOELECTRIC MEDICINE MARKET ANALYSIS BY TYPE

7.1 Overview by Type
7.2 Historical and Forecast Data
7.3 Analysis by Type
7.4 Implantable Electroceutical Devices Historic and Forecast Sales by Regions
7.5 Noninvasive Electroceutical Devices Historic and Forecast Sales by Regions

8 . GLOBAL BIOELECTRIC MEDICINE MARKET ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Chronic Pain Historic and Forecast Sales by Regions
8.5 Arrhythmia Historic and Forecast Sales by Regions
8.6 Failed Back Surgery Syndrome Historic and Forecast Sales by Regions
8.7 Cerebral Ischemia Historic and Forecast Sales by Regions
8.8 Urinary Incontinence Historic and Forecast Sales by Regions
8.9 Fecal Incontinence Historic and Forecast Sales by Regions
8.10. Gastroparesis Historic and Forecast Sales by Regions
8.11 Parkinson's Disease Historic and Forecast Sales by Regions
8.12 Tremors Historic and Forecast Sales by Regions
8.13 Depression Historic and Forecast Sales by Regions
8.14 Treatment-resistant Depression Historic and Forecast Sales by Regions
8.15 Epilepsy Historic and Forecast Sales by Regions
8.16 Others Historic and Forecast Sales by Regions

9 . GLOBAL BIOELECTRIC MEDICINE MARKET ANALYSIS BY END USE

9.1 Overview by End Use
9.2 Historical and Forecast Data
9.3 Analysis by End Use
9.4 Hospitals Historic and Forecast Sales by Regions
9.5 Clinics Historic and Forecast Sales by Regions
9.6 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL BIOELECTRIC MEDICINE MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BIOELECTRIC MEDICINE COMPANIES

11.1. Bioelectric Medicine Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF BIOELECTRIC MEDICINE INDUSTRY

12.1. Top Company Share Analysis
12.2. Market Concentration Rate
12.3. Medtronic plc
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Boston Scientific Corporation
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Abbott Laboratories Inc.
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. LivaNova PLC
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Cochlear Ltd.
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. MicroPort Scientific Corporation
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Sonova Group
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Nevro Corp.
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Axonics Modulation Technologies Inc.
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Neuronetics Inc.
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Second Sight Medical Products Inc
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. NeuroPace Inc.
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. BIOTRONIK Medico S.p.A.
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. Nurotron Biotechnology Co. Ltd.
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. MED-EL
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. Aleva Neurotherapeutics SA NeuroSigma Inc.
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. BioWave Corporation
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments
12.20. Soterix Medical Inc. (US)
- 12.20.1. Company Overview
- 12.20.2. Company Revenue
- 12.20.3. Products
- 12.20.4. Recent Developments
12.21. Bioinduction Ltd.
- 12.21.1. Company Overview
- 12.21.2. Company Revenue
- 12.21.3. Products
- 12.21.4. Recent Developments
12.22. GiMer Medical
- 12.22.1. Company Overview
- 12.22.2. Company Revenue
- 12.22.3. Products
- 12.22.4. Recent Developments
12.23. Cefaly
- 12.23.1. Company Overview
- 12.23.2. Company Revenue
- 12.23.3. Products
- 12.23.4. Recent Developments
12.24. BioControl Medical
- 12.24.1. Company Overview
- 12.24.2. Company Revenue
- 12.24.3. Products
- 12.24.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies